COVID-19

In the post-lockdown world, there’s still plenty to be done in community pharmacy to control res­piratory infections to keep staff and other patients well, writes infectious disease specialist Richard Everts 

Patients might be concerned about what they read and hear in the news regarding the use of renin–angiotensin system blockers during the COVID-19 pandemic. Cardiologist Chris Ellis reviews recent research and current recommendations

Ashley “The Eliminator” Bloomfield leapt to newly appointed health minister Chris Hipkins’ defence at a press conference at Auckland City Hospital yesterday when Pharmacy Today reporter Anna Lee pressed him on the $18 million package promised to pharmacy, only to find he knew nothing about it 

The eligibility criteria for the $18 million package allocated to pharmacy in June has finally been revealed, but the sector has been left scratching its head as to who will actually receive any money given the stringent criteria

The country’s 20 DHBs are urging community pharmacies in serious financial difficulty due to the impact of COVID-19 to see if they are eligible for a portion of an $18 million funding package

Average weekly retail sales are still lagging 5 per cent behind this time last year, according to the latest figures from RPM Retail

A vaccine against COVID-19 is urgently needed if we’re to stop the virus spreading and prevent potentially millions of further deaths. We’re now one step closer to that goal

The COVID-19 lockdown inspired many people to go out jogging – leading to more claims for running injuries just as sports-related claims fell 

An Auckland pharmacy is struggling to survive after the majority of their patients unexpectedly vanished four months ago – and didn’t come back

The experimental COVID-19 decoy drug made by New Zealand researchers has been found in laboratory tests to slash the coronavirus’ infectivity